Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neogene Therapeutics
Biotech
AstraZeneca drops lead TCR therapy from $200M Neogene buy
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell therapy clearout.
James Waldron
Jul 29, 2025 4:13am
AstraZeneca sets out vision for cell therapy 'library'
Dec 5, 2022 8:45am
AstraZeneca inks $200M solid tumor TCR cell therapy buyout
Nov 29, 2022 6:40am
Abbott CEO adds chair to title as White retires—Chutes & Ladders
Dec 17, 2021 9:30am
Neogene taps Gritstone CMO to lead T-cell therapies into clinic
Dec 16, 2021 10:35am
Sanofi-backed Jeito snags $630M fund for 12-15 European biotechs
Sep 20, 2021 1:00am
